Specialty Pharma Journal

taglinebanner468x60

Sun05202012

Last update 07:00:00 PM EST

CDC Proposing Test for Hepatitis C for All Baby Boomers

CDC Proposing Test for Hepatitis C for All Baby Boomers

Today, the Center for Disease Control (CDC) announced that they are proposing that all baby boomers get tested for hepatitis C.

The baby boomers consist of anyone born between the years 1945 to 1965,...

Read more...

FDA Approves Digestive Care Inc's NDA for Pertzye

FDA Approves Digestive Care Inc's NDA for Pertzye

BETHLEHEM, Pa., May 18, 2012-- Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERT...

Read more...

New Drug Shows Positive Results for Elderly Patients with Chronic Leukemia

New Drug Shows Positive Results for Elderly Patients with Chronic Leukemia

According to interim findings from a clinical trial, the experimental drug ibrutinib shows good results thus far for treatment of elderly patients with chronic lymphocytic leukemia (CLL).

The trial w...

Read more...

J&J’s Prostate Cancer Drug Shows Good Results

J&J’s Prostate Cancer Drug Shows Good Results

A mid-stage trial shows that adding Johnson & Johnson’s drug, Zytiga, for advanced prostate cancer, to hormone therapy before surgery eradicates tumors in certain men with high-risk forms of the d...

Read more...

Early Results Show Promise of Breast Cancer Vaccine

Early Results Show Promise of Breast Cancer Vaccine


Researchers reported positive results in the development of an experimental breast cancer vaccine.

According to a study led by the University of Texas MD Anderson Cancer Center, for women who had bee...

Read more...

Experimental Combo Drug for Melanoma Slows Cancer

Experimental Combo Drug for Melanoma Slows Cancer

A small clinical trial showed that two drugs, being developed by GlaxoSmithKline, slowed the progress of advanced melanoma with less side effects than the current therapies available.

The two experim...

Read more...

1 of 6 Loading
Study Shows Pfizer’s Xalkori Eliminates Certain Child Cancers

Study Shows Pfizer’s Xalkori Eliminates Certain Child Cancers

Researchers Identify Most Likely MS Patients to Develop a Rare Brain Infection

Researchers Identify Most Likely MS Patients to Develop a Rare Brain Infection

Messaging in Anticoagulants Category Ahead of Plavix Patent Loss

Messaging in Anticoagulants Category Ahead of Plavix Patent Loss

Pfizer’s Kidney Cancer Drug Fails to Meet Primary Endpoint

Pfizer’s Kidney Cancer Drug Fails to Meet Primary Endpoint

IDF Requests Exemption of Immunoglobulin from Biosimilars Pathway

IDF Requests Exemption of Immunoglobulin from Biosimilars Pathway

Study Results Show Pazopanib’s Benefits for Patients with Metastatic Soft-Tissue Sarcoma

Study Results Show Pazopanib’s Benefits for Patients with Metastatic Soft-Tissue Sarcoma

Specialty Pharma Journal Newsletter

Sign up here for our e-newsletters and stay informed with the latest specialty news, events, and resources delivered to your inbox

Medical News

Settings

Allergy/Asthma

Dymista Shows Positive Results in Three Clinical Studies

Dymista Shows Positive Results in Three Clinical Studies

 Meda (sto:MEDAA) announced today positive results of three studies of MP29...

Growth Hormone

Children on growth hormone more likely to have diabetes

Children on growth hormone more likely to have diabetes Type 2 diabetes is eight and a half times more common among children in the Unit...

Hemophilia

CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period

CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period Commitment will help WFH’s "Close the Gap" campaign aimed at improving healthcar...

Hereditary Angioedema

CSL Behring Initiates SubQ Administration of C1-esterase Inhibitor in Patients with HAE

CSL Behring Initiates SubQ Administration of C1-esterase Inhibitor in Patients with HAE

CSL Behring announced today that it has initiated an international phase I/II st...

Hormonal Therapies

Pfizer expects to pay almost $1 Billion to settle hormone replacement litigation

Pfizer expects to pay almost $1 Billion to settle hormone replacement litigation Pfizer Inc. (PFE) expects to pay at least $772 million to resolve all of the pro...

Immune Deficiencies

IDF Requests Exemption of Immunoglobulin from Biosimilars Pathway

IDF Requests Exemption of Immunoglobulin from Biosimilars Pathway

Baltimore, MD - In an effort to voice concern on biosimilars pathways for patien...

Endocrinology

First Cushing’s Syndrome Treatment Approved

First Cushing’s Syndrome Treatment Approved

The FDA recently approved Corcept Therapeutics’ drug, Korlym (mifepristone), for...

Hematopoietics

Study Shows Preventive Defibrotide May Help Kids after Hematopoietic Stem Cell Transplant

Study Shows Preventive Defibrotide May Help Kids after Hematopoietic Stem Cell Transplant

European researchers found that in pediatric patients going through hematopoieti...

Hepatitis C

CDC Proposing Test for Hepatitis C for All Baby Boomers

CDC Proposing Test for Hepatitis C for All Baby Boomers

Today, the Center for Disease Control (CDC) announced that they are proposing th...

HIV

FDA Panel Recommends First At-Home HIV Test

FDA Panel Recommends First At-Home HIV Test

WASHINGTON — A panel of HIV specialists is recommending that U.S. regulators app...

Hematology

Highlights from ASH 2011

Highlights from ASH 2011

 Genomics finds potential treatment targets in new subtype of acute lymphoc...

Infectious Disease

FDA Expands Use for FilmArray Respiratory Panel

FDA Expands Use for FilmArray Respiratory Panel

The US Food and Drug Administration announced the expanded use for the FilmArray...

Posters & Abstracts

HIV153px140px
Read More

Trends & Reports

feb_stats
Read More

Chief Pharmacy Officer

chiefpharmacyofficer
Read More

Original Papers

rx
Read More

Research & Literature Reviews

InfectDis153px140px
Read More

©2012 SpecialtyPharmaJournal.com. All rights reserved.